FDA Has Questions About Tobramycin Powder
The Food and Drug Administration is questioning if tobramycin actually does help patients with cystic fibrosis to breathe better. The powdered version of the drug is an alternative to the nebulized version that is called Tobi. The FDA is only questioning the powdered form of the medication. A company called Novartis makes a drug called Tobi. It is a nebulized version of tobramycin. A nebulizer is an electric, or battery-powered machine that turns liquid medication into a fine mist that an adult or child can inhale into their lungs. Some nebulizers have a mouthpiece, and others have a face mask. … Continue reading